| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/10/1997 | CN1159190A Bioactive acetogenins and derivatives |
| 09/10/1997 | CN1159183A BIS-(2-haloethyl) aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
| 09/10/1997 | CN1158856A Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/10/1997 | CN1158855A Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmacueticals |
| 09/10/1997 | CN1158725A Use of 8,9-dehydroestrone as antioxidant |
| 09/10/1997 | CN1035821C Prepn. of 4-deoxy-4-epipodophyllotoxin derivatives |
| 09/10/1997 | CN1035817C Prepn. of triazolyl-substituted tertiary amino compounds and their salts |
| 09/09/1997 | US5665883 Treatment of pain, inflammation, migraine, emesis |
| 09/09/1997 | US5665860 Tetrapeptide amides |
| 09/09/1997 | US5665859 Molecules influencing the shedding of the TNF receptor, their preparation and their use |
| 09/09/1997 | US5665780 Reversal of multi-drug resistance by tetraarylethylenes |
| 09/09/1997 | US5665777 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
| 09/09/1997 | US5665772 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 09/09/1997 | US5665771 Platinum complexes |
| 09/09/1997 | US5665761 Infusion of less than 6 hours |
| 09/09/1997 | US5665760 Lyophilized thioxanthenone antitumor agents |
| 09/09/1997 | US5665751 Pharmaceutical composition for inhibiting the growth of cancers |
| 09/09/1997 | US5665716 24-homo vitamin D derivatives, process for their production and pharmaceutical preparations obtained therefrom |
| 09/09/1997 | US5665713 Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| 09/09/1997 | US5665703 GE3 compound |
| 09/09/1997 | US5665702 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| 09/09/1997 | US5665580 Antisense oligonucleotide inhibition of papillomavirus transformed cells |
| 09/09/1997 | US5665553 Methods for determining and modulating cellular redox potential and genotoxic states |
| 09/09/1997 | US5665380 Lipid vesicle fusion as a method of transmitting a biologically active material to a cell |
| 09/09/1997 | US5665357 Antibodies recognizing tumor associated antigen CA 55.1 |
| 09/09/1997 | US5665343 Polymeric platinum complex, preparation thereof, and anticancer agent comprising thereof |
| 09/09/1997 | US5665328 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 09/04/1997 | WO1997031949A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 09/04/1997 | WO1997031941A2 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | WO1997031936A2 Novel ortho-naphthoquinone derivatives, novel synthesis therefor, and their use in the inhibition of neoplastic cell growth |
| 09/04/1997 | WO1997031895A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | WO1997031657A2 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors |
| 09/04/1997 | WO1997031655A2 Modified cytokines for therapeutic use |
| 09/04/1997 | WO1997031630A1 Use of hexahydrolupulones as antibacterial and anticancer agents |
| 09/04/1997 | WO1997031625A1 Inhibition of selectin binding |
| 09/04/1997 | WO1997022699A3 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 09/04/1997 | WO1997016457A3 Anti-tumoral protein |
| 09/04/1997 | CA2247802A1 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | CA2247430A1 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors |
| 09/04/1997 | CA2247370A1 Use of hexahydrolupulones as antibacterial and anticancer agents |
| 09/04/1997 | CA2247308A1 Modified cytokines for therapeutic use |
| 09/04/1997 | CA2247208A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | CA2245932A1 Pharmaceutical compounds |
| 09/04/1997 | CA2198980A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/04/1997 | CA2198979A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/03/1997 | EP0792931A2 Products and methods for controlling the suppression of the neoplastic phenotype |
| 09/03/1997 | EP0792641A1 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 09/03/1997 | EP0792640A2 Use of (E)-1-(4'-(2-alkylaminoethioxy)-phenyl)-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes for inhibiting pathological conditions |
| 09/03/1997 | EP0792366A1 Enzyme gene therapy catalysing prodrug extracellular conversion |
| 09/03/1997 | EP0792360A2 Proteins involved in the regulation of cell-cell adhesion and uses thereof |
| 09/03/1997 | EP0792354A1 Targeted t lymphocytes |
| 09/03/1997 | EP0792292A2 Orphan receptor |
| 09/03/1997 | EP0792283A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH |
| 09/03/1997 | EP0792278A1 Tumor necrosis factor-gamma |
| 09/03/1997 | EP0792169A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
| 09/03/1997 | EP0792168A1 Novel tumor suppressor gene, hic-1 |
| 09/03/1997 | EP0792167A1 Monofunctional and/or polyfunctional polylysine conjugates |
| 09/03/1997 | EP0792154A1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 09/03/1997 | EP0792148A1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity |
| 09/03/1997 | CN1158617A RNA component of telomerase |
| 09/03/1997 | CN1158614A Novel compound, process for producing the same, and antitumor agent |
| 09/03/1997 | CN1158357A Gene regulating aureobasidin sensitivity |
| 09/03/1997 | CN1158262A External-use cream for treatment of breast cancer |
| 09/03/1997 | CN1158261A Chinese Patent medicine |
| 09/03/1997 | CN1035768C 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase |
| 09/02/1997 | US5663404 Antitumor agents; antiinflammatory agents |
| 09/02/1997 | US5663380 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 09/02/1997 | US5663375 Cell proliferation |
| 09/02/1997 | US5663347 Regulators of cell proliferation and differentiation; treatment of skin disorders; anticarcinognic agents |
| 09/02/1997 | US5663346 Enzyme inhibitors |
| 09/02/1997 | US5663337 Pharmaceutically active benzoquinazoline compounds |
| 09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
| 09/02/1997 | US5663312 Chemical intermediates for rna and dna for gene expression |
| 09/02/1997 | US5663292 Antagonist peptides; regulation of secretion of corticotropin |
| 09/02/1997 | US5663201 Complexes with iron or aluminum |
| 09/02/1997 | US5663197 2-(1-hydroxyethyl)-5-hydroxynaphtho[2,3-b]furan-4,9-dione and antitumor agents comprising this compound |
| 09/02/1997 | US5663179 Can sensitize multidrug resistant cancer cells to chemotherapeutic agents |
| 09/02/1997 | US5663177 Anticarcinogenic agents or antitumor agents |
| 09/02/1997 | US5663168 Use of compositions for combating tumour diseases |
| 09/02/1997 | US5663159 Prodrugs of phosphonates |
| 09/02/1997 | US5663157 For treating hyperproliferative diseases |
| 09/02/1997 | US5663151 Sulfated α-glycolipid derivatives as cell adhesion inhibitors |
| 09/02/1997 | US5663149 Anticarcinogenic agents related to dolastatin |
| 09/02/1997 | US5663142 For treating thrombosis, protein s deficiency, sepsis, inflammation and cancer |
| 09/02/1997 | US5663071 An isolated polynucleotide |
| 09/02/1997 | US5663070 Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM |
| 09/02/1997 | US5662903 Compositions for the prevention and treatment of viral-induced tumors |
| 09/02/1997 | US5662902 Aspergillus fermentation extract |
| 09/02/1997 | US5662899 Prepared by culturing human monocytes and lymphocytes in a culture medium containing 1,25-dihydroxy vitamin d3 and granulocyte-macrophage colony stimulating factor |
| 09/02/1997 | US5662896 Directly administering a vector construct which directs the expression of antitumor agents |
| 08/28/1997 | WO1997031119A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | WO1997031116A2 Recombinant ribonuclease proteins |
| 08/28/1997 | WO1997031019A2 Antipathogenic peptides and compositions comprising them |
| 08/28/1997 | WO1997031003A1 Camptothecin derivatives and the use thereof as antitumor agents |
| 08/28/1997 | WO1997031002A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
| 08/28/1997 | WO1997030992A1 Inhibitors of farnesyl protein transferase |
| 08/28/1997 | WO1997030985A1 Benzothiophenes, and formulations and methods, using same |
| 08/28/1997 | WO1997030732A1 Liposomal-viral dna complexes for treating disease |
| 08/28/1997 | WO1997030721A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/28/1997 | WO1997030709A1 Benzothiophenes, formulations containing same, and methods |